Description

SPASMOHEAL 80 MG

Indications

SPASMOHEAL 80 MG is primarily indicated for the management of smooth muscle spasms associated with various gastrointestinal, biliary, and urinary tract disorders. It is commonly used to alleviate symptoms of conditions such as irritable bowel syndrome (IBS), biliary colic, and renal colic. The medication helps to reduce the frequency and intensity of spasms, thereby improving patient comfort and quality of life.

Mechanism of Action

SPASMOHEAL 80 MG contains the active ingredient mebeverine hydrochloride, which is an antispasmodic agent. Its mechanism of action involves the direct relaxation of the smooth muscle in the gastrointestinal tract. Mebeverine works by inhibiting the influx of calcium ions into the smooth muscle cells, which prevents muscle contraction. This action helps to relieve spasms and reduce abdominal pain without affecting normal gastrointestinal motility.

Pharmacological Properties

SPASMOHEAL 80 MG exhibits a selective action on the smooth muscle of the gastrointestinal tract, making it effective in treating spasmodic conditions. The pharmacokinetics of mebeverine indicate that it is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1-2 hours. The drug is extensively metabolized in the liver, and its metabolites are primarily excreted through the urine. The half-life of mebeverine is approximately 1.5 hours, allowing for effective symptom control with appropriate dosing.

Contraindications

SPASMOHEAL 80 MG is contraindicated in patients with known hypersensitivity to mebeverine or any of the excipients in the formulation. It should not be used in patients with severe hepatic or renal impairment, as these conditions may affect the metabolism and excretion of the drug. Additionally, the medication is not recommended for use in children under the age of 12 years unless specifically prescribed by a healthcare professional.

Side Effects

Like all medications, SPASMOHEAL 80 MG may cause side effects, although not everyone experiences them. Common side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Some patients may also experience dizziness, headache, or skin rashes. In rare cases, allergic reactions may occur, presenting as swelling, itching, or difficulty breathing. Patients are advised to seek medical attention if they experience any severe or persistent side effects.

Dosage and Administration

The recommended dosage of SPASMOHEAL 80 MG for adults is one tablet taken three times daily, preferably 20 minutes before meals. The dosage may be adjusted based on the patient’s response and the severity of symptoms. It is important to swallow the tablet whole with a glass of water and not to chew or crush it to ensure proper release of the medication. For optimal results, patients should adhere to the prescribed dosing regimen and consult their healthcare provider if symptoms persist or worsen.

Interactions

SPASMOHEAL 80 MG may interact with other medications, potentially altering their effectiveness or increasing the risk of adverse effects. It is essential for patients to inform their healthcare provider about all medications they are currently taking, including over-the-counter drugs and herbal supplements. Specific interactions have not been extensively documented; however, caution is advised when combining SPASMOHEAL with other antispasmodics or medications that affect gastrointestinal motility.

Precautions

Before initiating treatment with SPASMOHEAL 80 MG, patients should undergo a thorough medical evaluation to rule out any underlying conditions that may require alternative treatment approaches. Special caution is warranted in patients with a history of gastrointestinal obstruction or severe constipation. The safety of SPASMOHEAL during pregnancy and lactation has not been established, so it should only be used if the potential benefits outweigh the risks. Patients should also be advised not to drive or operate heavy machinery if they experience dizziness or drowsiness while taking this medication.

Clinical Studies

Several clinical studies have evaluated the efficacy and safety of SPASMOHEAL 80 MG in the treatment of smooth muscle spasms. In a randomized controlled trial involving patients with irritable bowel syndrome, SPASMOHEAL demonstrated a significant reduction in abdominal pain and discomfort compared to placebo. Another study highlighted its effectiveness in managing biliary colic, showing a marked improvement in symptom relief and patient satisfaction. These studies support the use of SPASMOHEAL as a reliable option for individuals suffering from various spastic conditions.

Conclusion

SPASMOHEAL 80 MG is a well-established antispasmodic medication that provides effective relief from smooth muscle spasms associated with gastrointestinal and urinary tract disorders. Its mechanism of action, pharmacological properties, and clinical efficacy make it a valuable option for patients experiencing discomfort due to spasmodic conditions. As with any medication, it is crucial for patients to use SPASMOHEAL responsibly and under the guidance of a healthcare professional to ensure safety and optimal therapeutic outcomes.